|
1 |
Optic pathway gliomas: A review Pub Med: Neurosurg Focus. 2007;23(5):E2.
A brief abstract about optic nerve glioma.
|
|
2 |
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma Pub Med abstract: J Neurosurg. 2007 Jul;107(1 Suppl):5-10
|
|
3 |
Medulloblastoma in childhood: new biological advances Pub Med abstract: Lancet Neurol. 2007 Dec;6(12):1073-85
|
|
5 |
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan RATIONALE: CT-322 may stop the growth of glioblastoma multiforme by blocking blood flow to the tumor. Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving CT-322 together with irinotecan may kill more tumor cells.
|
|
7 |
Initial management of childhood brain tumors: neurosurgical considerations J Child Neurol. 2008 Oct;23(10):1136-48.
|
|
10 |
Designer therapies for glioblastoma multiforme Ann N Y Acad Sci. 2008 Oct;1142:108-32
|
|
11 |
Biological background of pediatric medulloblastoma and epedymoma: A review from a translational research perspective Judith M. deBont, Roger J. Packer; Erna Michiels, Monique L denBoer, and Rob Pieters; Neuro-Oncology, Duke University Press, 2008 10(6)
|